Clinical trial tests cord-blood cells to treat macular degeneration
UIC is part of a national phase 2 clinical trial to evaluate the safety and tolerability of using cells derived from multipotent umbilical cord cells to treat age-related macular degeneration, the most common cause of vision ...
Jul 20, 2016
0
85